We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » HGH Monograph Proves Viability of Biogenerics, GPhA Says
HGH Monograph Proves Viability of Biogenerics, GPhA Says
May 17, 2005
The U.S. Pharmacopeia’s (USP) new human growth hormone (HGH) monograph adds more weight to the argument that follow-on biologics can be accurately characterized using current scientific techniques, contends the Generic Pharmaceutical Association (GPhA).